0001417926 2025-01-01 2025-12-31 0001417926 2025-06-30 0001417926 2026-06-12 0001417926 2025-10-01 2025-12-31 iso4217:USD shares iso4217:USD shares true FY 0001417926 No No Yes Yes 10-K/A true 2025-12-31 --12-31 2025 false INVO FERTILITY, INC. NV 001-39701 20-4036208 5582 Broadcast Court Sarasota FL 34240 (978) 878-9505 Common Stock, $0.0001 par value per share IVF NASDAQ Non-accelerated Filer true false false false false 2185985 0.0001 1786035 None. This Amendment No. 1 to Form 10-K (this “Amendment” or “Amendment No. 1”) amends the Annual Report on Form 10-K for the fiscal year ended December 31, 2025 originally filed on June 2, 2026 (the “Original Filing”) by INVO Fertility, Inc., a Nevada corporation (“INVO,” the “Company,” “we,” or “us”). We are filing this Amendment to provide the information required by Part III of Form 10-K, as we did not file our definitive proxy statement within 120 days of the end of the fiscal year ended December 31, 2025. The references in the Original Filing to the incorporation by reference of our definitive proxy statement into Part III of the Original filing are hereby deleted. In addition, Item 15 of Part IV is being amended to include currently dated certifications in accordance with Rule 13a-13(a) promulgated by the SEC under the Securities Exchange Act of 1934, as amended, with paragraphs 3, 4, and 5 omitted, since no financial statements are contained within this Amendment. Because no financial statements are contained within this Amendment, the Company is not including certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 or any disclosures with respect to Items 307 or 308 of Regulation S-K.   Except as described above, no other changes have been made to the Original Filing. The Original Filing continues to speak as of the date of the Original Filing, and we have not updated the disclosures contained therein to reflect any events which occurred at a date subsequent to the filing of the Original Filing. Accordingly, this Amendment should be read in conjunction with our Original Filing and our other filings made with the SEC subsequent to the filing of the Form 10-K.   false false false false false false true We do <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_907_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20250101__20251231_z2ao3P68rWok">no</span>t have any policies and practices on the timing of awards of stock options or other equity grants in relation to the disclosure of material nonpublic information. In 2025, we did not award any stock options or other equity grants to any executive officer in the period beginning four business days before the filing of any periodic report on Form 10-Q or 10-K or the filing or furnishing of a current report on Form 8-K that disclosed material non-public information and ending one business day after the filing or furnishing of such report. false